MSKCC-23-278
Phase II
OPEN TO ACCRUAL
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
P-HEMONC-CUIMC-23-040
Phase II
OPEN TO ACCRUAL *
Phase 2 Study BRIDGING PRE-TRANSPLANT INFLAMMATORY DAMPENING for PRIMARY IMMUNE REGULATORY DISORDERS (BRIDGE Trial)
X4P-001-110
Phase III
OPEN TO ACCRUAL *
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections